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ABSTRACT
VANDER BERG, J. D., J. H. P. M. VANDERVELDE, E. A. C. DEWAARD, H. BOSMA, H. H. C. M. SAVELBERG, N. C. SCHAPER,
J. P. W. VANDENBERGH, P. P. M. M. GEUSENS, M. T. SCHRAM, S. J. S. SEP, C. J. H. VANDERKALLEN, R. M. A. HENRY, P. C.
DAGNELIE, S. J. P. M. EUSSEN, M. C. J. M. VAN DONGEN, S. KÖHLER, A. A. KROON, C. D. A. STEHOUWER, and A. KOSTER.
Replacement Effects of Sedentary Time onMetabolic Outcomes: TheMaastricht Study.Med. Sci. Sports Exerc., Vol. 49, No. 7, pp. 1351–1358,
2017. Introduction: Sedentary time has been associated with detrimental health effects, so in some countries, guidelines to reduce sedentary
time have been developed. As reducing sedentary time inevitably results in more nonsedentary time, effects of this reduction may depend
on the activity with which it is replaced. Purpose: This study aimed to examine associations of theoretical reallocations of sedentary time
to standing or stepping with cardiometabolic outcomes and type 2 diabetes. Methods: We included 2213 participants (51% men, mean T
SD age = 60.0 T 8.1 yr) of the Maastricht Study who were asked to wear an accelerometer 24 hIdj1 for a week. We calculated daily
sedentary, standing, and stepping time. An isotemporal substitution modeling approach was applied to examine effects on waist circum-
ference; body mass index; cholesterol, triacylglycerol, glucose, and insulin levels; metabolic syndrome; and type 2 diabetes. Results:
Replacement of sedentary time (30 minIdj1) with stepping was associated with lower odds for metabolic syndrome (odds ratio [OR] = 0.72,
95% confidence interval [CI] = 0.66–0.78) and type 2 diabetes (OR = 0.79, 95% CI = 0.72–0.87), more favorable waist circumference (B =
j1.42, 95% CI =j1.78 toj1.06), and body mass index (B =j0.48, 95% CI =j0.62 toj0.35) and improved cholesterol, triacylglycerol,
glucose, and insulin levels. Replacing sedentary time with standing was associated with lower odds for metabolic syndrome and type 2
diabetes and favorable outcomes in waist circumference, cholesterol, triacylglycerol, and insulin levels. Conclusion: Theoretical re-
placements of sedentary time with nonsedentary time (both standing and stepping) were associated with lower odds for metabolic syndrome,
type 2 diabetes, and beneficial metabolic outcomes. These results could be important for the general population, including those who
cannot meet physical activity guidelines. Consideration should be given to developing recommendations for daily reallocating sed-
entary time. Key Words: SEDENTARY LIFESTYLE, DIABETES MELLITUS TYPE 2, METABOLIC SYNDROME, ACCELEROMETRY,
ISOTEMPORAL SUBSTITUTION MODELING
EPIDEMIOLOGY
Address for correspondence: Annemarie Koster, Ph.D., Department of Social Medicine, Maastricht University, Maastricht, the Netherlands; E-mail:
a.koster@maastrichtuniversity.nl.
Submitted for publication October 2016.
Accepted for publication February 2017.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article
on the journal_s Web site (www.acsm-msse.org).
0195-9131/17/4907-1351/0
MEDICINE & SCIENCE IN SPORTS & EXERCISE
Copyright  2017 by the American College of Sports Medicine
DOI: 10.1249/MSS.0000000000001248
1351
Copyright © 2017 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
S
edentary behavior, which refers to any waking be-
havior that is characterized by an energy expenditure
e1.5 METs while in a sitting or reclining position
such as watching TV or using the computer (24), has been
associated with several adverse health outcomes, including
cardiometabolic risk factors (e.g., waist circumference,
cholesterol and triacylglycerol levels, and insulin resistance)
(5,10), cardiovascular disease (4,27), type 2 diabetes (4,27),
and premature mortality (4,27).
Therefore, in some countries, health guidelines to reduce
sedentary time have been developed by public health orga-
nizations and scientific institutions (7,8), and the Australian
government has even published a sedentary behavior guideline
(2). However, specific recommendations for the amount of
sedentary time that should be reduced are lacking. To develop
these recommendations, studies on the health effects of reducing
sedentary time are needed. More specifically, as reducing sed-
entary time inevitably results in larger amounts of nonsedentary
time, which can vary from light physical activity (LPA) to
vigorous physical activity, the effects of reducing sedentary time
may depend on the activity with which it is replaced. Therefore,
studies examining the effects of reduced sedentary time replaced
with other types of behaviors are required.
An isotemporal substitution model (ISM) can be used to
examine the effects of the theoretical replacement of sedentary
time by nonsedentary time, like standing or stepping (22).
Previous studies that have used an ISM approach demon-
strated that a theoretical replacement of sedentary time with
LPA or moderate to vigorous physical activity (MVPA) was
associated with favorable health outcomes, including a re-
duction in body mass index (BMI) (12,14,17,18) and waist
circumference (6,11,12,17,18), and improved markers of
insulin sensitivity (6,29), levels of cholesterol (6,11,14,18),
triacylglycerol (6,11,14,18), and glucose (6,18,29).
Although previous studies have used accelerometry data
to assess sedentary time, in most studies sedentary time was
solely based on acceleration data which cannot discriminate
between postures. Consequently, standing time may have
been misclassified as sedentary time or vice versa (20,21).
Therefore, we used the activPAL accelerometer which
classifies sedentary behavior (sitting or lying) using data on
posture, as this has shown to be an accurate method for
assessing sedentary behavior (13,20).
The aim of this study was to examine the cross-sectional
associations of a theoretical reallocation of sedentary behavior
(sitting or lying) to standing or stepping with cardiometabolic
outcomes, metabolic syndrome, and type 2 diabetes in 2213
adults 40–75 yr old.
METHODS
Study Population
We used data from the Maastricht Study, an observational
prospective population-based cohort study. The rationale
and the methodology have been described previously (23).
In brief, the study focuses on the etiology, pathophysiology,
complications, and comorbidities of type 2 diabetes and is
characterized by an extensive phenotyping approach. Eligible
participants were individuals between 40 and 75 yr of age and
living in the southern part of the Netherlands. Participants
were recruited through mass media campaigns and from the
municipal registries and the regional Diabetes Patient Registry
via mailings. Recruitment was stratified according to known
type 2 diabetes status, with an oversampling of individuals
with type 2 diabetes, for reasons of efficiency. This study
included cross-sectional data from 3451 participants, who
completed the baseline survey between November 2010 and
September 2013. The examinations of each participant were
performed within a time window of 3 months. Participants with
type 1 diabetes, latent autoimmune diabetes in adults, steroid-
induced diabetes, or diabetes after pancreatectomy (n = 41)
were excluded. After further successively excluding partici-
pants who did not receive an accelerometer because of logistics
(n = 668), whose accelerometer measurement failed (n = 135),
or who had missing data on other measures (n = 394), a total of
2213 participants were included in the present analyses.
The study was approved by the institutional medical ethical
committee (NL31329.068.10) and the Minister of Health,
Welfare and Sports of the Netherlands (permit no. 131088-
105234-PG). All participants gave written informed consent.
Measurements
Cardiometabolic outcomes. The following cardio-
metabolic outcomes were used: waist circumference, BMI,
office blood pressure, HDL cholesterol, total-to-HDL cholesterol
ratio, triacylglycerol, fasting glucose, 2 h postload glucose,
HbA1c, fasting insulin, metabolic syndrome, and type 2 diabetes.
Waist circumference, weight, and height were measured as
described elsewhere (23). BMI was calculated as kilograms
per square meters. Office blood pressure was determined
three times on the right arm after a 10-min rest period, using a
noninvasive blood pressure monitor (Omron 705IT; OMRON,
Kyoto, Japan). All available measurements were used to cal-
culate the average blood pressure. Fasting blood samples were
used for laboratory assessment of total cholesterol, HDL
cholesterol, triacylglycerol, glucose, HbA1c, and insulin levels
(23). Total-to-HDL cholesterol ratio was calculated by divid-
ing total cholesterol by HDL cholesterol. To determine 2 h
posttload glucose and glucose metabolism status, all partici-
pants (except those who use insulin) underwent a standardized
75-g oral glucose tolerance test after an overnight fast as de-
scribed elsewhere (23). The metabolic syndrome was defined
according to the ATPIII guidelines by the presence of three or
more of the following criteria: 1) waist circumference Q102 cm
for men and Q88 cm for women, 2) serum triacylglycerol level
Q1.7 mmolILj1, 3) HDL cholesterol level G1.03 mmolILj1 for
men and G1.30 mmolILj1 for women, 4) fasting glucose
level Q5.6 mmolILj1 or use of antidiabetic medications
(insulin or oral agents), or 5) systolic blood pressure Q130 mm
Hg and/or diastolic blood pressure Q85 mm Hg, and/or use of
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antihypertensive medications (1). To determine type 2 dia-
betes, participants were categorized according to the World
Health Organization"s 2006 criteria (28), into normal glucose
metabolism (NGM), impaired fasting glucose (fasting plasma
glucose 6.1–6.9 mmolILj1 and 2 h plasma glucose (after
glucose load) G7.8 mmolILj1), impaired glucose tolerance
(fasting plasma glucose G 7.0 mmolILj1 and 2 h plasma glu-
cose Q7.8–11.1 mmolILj1), or type 2 diabetes (fasting plasma
glucose Q7.0 mmolILj1 or 2 h plasma glucose Q11.1 mmolILj1).
Impaired fasting glucose and impaired glucose tolerance were
combined into prediabetes. Participants on diabetes medica-
tion and without the diagnosis of type 1 diabetes were also
considered to have type 2 diabetes. For the analyses with type 2
diabetes as outcome measure, we used the categories: hav-
ing type 2 diabetes and not having type 2 diabetes (NGM
and prediabetes).
Accelerometry data. Daily activity levels were mea-
sured using the activPAL3i physical activity monitor (PAL
Technologies, Glasgow, UK), as described elsewhere (26).
Participants were asked to wear the accelerometer for eight
consecutive days, without removing it at any time. Data
from the first day were excluded from the analysis because
participants performed physical function tests at the research
center after the device was attached. In addition, data from
the final wear day providing e14 waking hours of data were
excluded from the analysis. Participants were included if
they provided at least one valid day (Q10 h of waking data).
The total amount of sedentary time was based on the sed-
entary posture (sitting or lying) and calculated as the mean
time spent in a sedentary position during waking time per day.
The method used to determine waking time has been de-
scribed elsewhere (26). The total amount of standing time was
based on the standing posture and calculated as the mean time
spent standing during waking time per day. The total amount
of stepping was based on the stepping posture and calculated
as the mean time stepping during waking time per day.
Covariates. Covariates, which were extracted from a
questionnaire, included sex, age, level of education, smoking
status, alcohol consumption, energy intake, mobility limita-
tion, and prevalent cardiovascular disease. Level of education
was categorized into low, medium, and high, and smoking
status was categorized into never, former, and current smoker.
Alcohol consumption was categorized into nonconsumers,
low consumers (e7 glasses per week for women and e14
glasses per week for men), and high consumers (97 glasses per
week for women and 914 glasses per week for men). Energy
intake was obtained from a food frequency questionnaire and
calculated as the mean energy intake (kcal) per day. Mobility
limitation was obtained from the 36-Item Short Form Health
Survey questionnaire and was defined as having difficulty
walking 500 m or climbing the stairs. Prevalent cardiovascular
disease was defined as a self-reported history of myocardial
infarction, cerebrovascular infarction or hemorrhage, or per-
cutaneous artery angioplasty of, or vascular surgery on, the
coronary, abdominal, peripheral, or carotid arteries. The use of
lipid-modifying, antihypertensive, and glucose-lowering
medication was assessed during a medication interview. De-
pression was assessed by the structured Mini-International
Neuropsychiatric Interview (25). Lastly, glucose metabolism
status (using the categories NGM, prediabetes, and type 2
diabetes) was used as a covariate in all analyses except those
with metabolic syndrome and type 2 diabetes.
Statistical Analysis
Characteristics of the total study population and according to
sex-specific tertiles (to obtain equal distributions of men and
women) of sedentary time were summarized as mean T SD or as
numbers and percentages. The variables total-to-HDL cholesterol
ratio, triacylglycerol, fasting glucose, 2-h postload glucose, fasting
insulin, and HbA1c had a skewed distribution and were described
using the median and the interquartile range. For the analyses,
these variables were transformed using natural logarithm.
Associations of sedentary time, standing, and stepping (all
expressed per 30 min by dividing total time in minutes by 30)
with the cardiometabolic outcomes were examined for each
type of behavior and each outcome separately, using linear
regression analysis for the continuous variables and logistic
regression analysis for metabolic syndrome and type 2 dia-
betes. The associations were adjusted for sex, age, level of
education, waking time, smoking status, alcohol consumption,
energy intake, mobility limitation, prevalent cardiovascular
disease, depression, and antihypertensive and lipid-modifying
medication (the metabolic syndrome and type 2 diabetes were
not adjusted for medication use). The associations were also
adjusted for glucose metabolism status to take into account the
oversampling of participants with type 2 diabetes in the
Maastricht Study (metabolic syndrome and type 2 diabetes
were not adjusted for glucose metabolism status). Finally, all
associations, except those describing waist circumference,
BMI, andmetabolic syndrome, also includedBMI as covariate.
The ISM approach was applied to the cardiometabolic
outcomes that were statistically significantly associated in
the regression analyses. The ISM analysis involves a linear
regression model that includes all types of behavior (sed-
entary, standing, and stepping) and total waking time. By
dropping one type of behavior (e.g., sedentary behavior), the
coefficients of another type of behavior (e.g., standing), will
represent the estimated effect of replacing 30 min sedentary
time with 30 min standing. The following estimated re-
placement effects were modeled: sedentary time replaced by
standing and replaced by stepping and standing replaced by
stepping. Because all types of behavior (with all types of
intensities) were included in the models, the estimated re-
placement effects of the behaviors were independent of one
another. We used time blocks of 30 min because a minimum
of 30 min MVPA per day is required to meet the physical
activity guidelines (19). The associations were adjusted as
described before. In all analyses, the assumption of linearity
was verified and multicollinearity was not indicated (vari-
ance inflating factors were G2.5).
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In additional analyses, we tested for interaction between all
types of behavior (sedentary time, standing, and stepping) and
glucose metabolism status. A P value G0.10 for interaction
was considered statistically significant. Further, the linear
regression analyses were repeated with replacement of office
blood pressure with 24/h average ambulatory blood pressure
(n = 1956). All analyses were conducted with IBM SPSS
Statistics 22.0 (IBM Corp., Armonk, NY).
RESULTS
A total of 2213 participants (51% men) with an average
age of 60.0 T 8.1 yr were included. They provided on av-
erage 6.3 T 1.2 valid days of accelerometry data, although
most participants (57%) provided seven valid days. Average
waking time was 15.7 T 0.9 hIdj1, of which 9.4 T 1.7 h
(60%) was spent in a sedentary position. The remaining
waking hours were spent standing (4.3 T 1.3 h; 27%) and
stepping (2.0 T 0.7 h; 13%). Characteristics of the total study
population and according to sex-specific tertiles of sedentary
time are presented in Table 1.
To determine which outcome measures should be studied
using the ISM approach, associations between all types of
behavior and the cardiometabolic outcomes were examined
separately using regression analyses. Sedentary time was, in
the fully adjusted model, statistically significantly associated
with a larger waist circumference, a higher BMI, a lower HDL
cholesterol level, a higher total-to-HDL cholesterol ratio, a
higher triacylglycerol level, 2/h postload glucose, and a higher
fasting insulin level. Standing and stepping were associated
with a lower waist circumference, a lower BMI, a higher HDL
cholesterol level, a lower total-to-HDL cholesterol ratio, and a
lower triacylglycerol level, 2/h postload glucose, and a lower
fasting insulin level. No statistically significant associations
were observed between any of the types of behavior and blood
pressure, fasting glucose levels, and HbA1c. By contrast, all
types of behavior were associated with metabolic syndrome
and type 2 diabetes (see Table, Supplemental Digital Content 1,
Associations of sedentary time, standing, and stepping with
cardiometabolic outcomes, http://links.lww.com/MSS/A885).
Table 2 presents the estimated effects of replacing 30 min
of one type of behavior with another. After adjustment for
confounders, a daily replacement of 30 min of sedentary time
TABLE 1. Characteristics of the total study population and according to sex-specific tertiles of sedentary time per day.
Sex-Specific Tertiles of Mean Sedentary Time per Day
Total Population (N = 2213) Tertile 1 (n = 737) Tertile 2 (n = 739) Tertile 3 (n = 737)
Range sedentary time (hIdj1) in men 4.3–15.9 4.3–9.3 9.3–10.6 10.6–15.9
Range sedentary time (hIdj1) in women 2.5–14.4 2.5–8.1 8.1–9.5 9.5–14.4
Age (yr) 60.0 T 8.1 59.0 T 8.2 60.5 T 8.0 60.6 T 8.1
Sex (% men) 51.2 51.2 51.2 51.2
Educational level (%)
Low 32.8 33.9 32.3 32.0
Medium 28.4 31.1 27.9 26.2
High 38.9 35.0 39.8 41.8
Smoking status (%current) 12.1 10.3 9.3 16.6
Alcohol use (% high) 25.7 26.1 26.0 25.1
Energy intake (kcalIdj1) 2168.8 T 599.4 2201.6 T 607.7 2174.4 T 586.5 2130.3 T 602.5
Mobility limitation (%) 20.1 14.1 19.1 27.0
Lipid-modifying medication (%) 37.0 30.3 36.8 44.0
Antihypertensive medication (%) 40.6 31.3 40.1 50.3
Glucose-lowering medication (%) 22.3 14.8 19.9 32.3
Cardiovascular disease history (%) 16.4 14.2 16.1 19.0
Depression (%) 3.4 3.1 2.2 5.0
Glucose metabolism status (%)
Normal 56.5 64.6 59.4 45.5
Prediabetes 15.4 15.2 15.6 15.6
Type 2 diabetes 28.1 20.2 25.0 38.9
Waist circumference (cm) 95.7 T 13.7 92.3 T 12.6 95.1 T 12.7 99.6 T 14.8
BMI (kgImj2) 27.0 T 4.5 26.1 T 4.3 26.9 T 4.1 28.1 T 4.9
Systolic blood pressure (mm Hg) 135.1 T 18.1 134.1 T 18.3 135.3 T 17.7 135.8 T 18.3
Diastolic blood pressure (mm Hg) 76.2 T 9.9 75.9 T 10.1 76.0 T 9.6 76.6 T 10.1
HDL cholesterol (mmolILj1) 1.6 T 0.5 1.7 T 0.5 1.6 T 0.5 1.4 T 0.5
Total-to-HDL cholesterol ratio 3.4 (2.8–4.2) 3.2 (2.7–4.1) 3.4 (2.8–4.2) 3.5 (2.9–4.4)
Triacylglycerol (mmolILj1) 1.2 (0.9–1.7) 1.1 (0.8–1.5) 1.2 (0.9–1.7) 1.4 (1.0–1.9)
Fasting glucose (mmolILj1) 5.5 (5.1–6.6) 5.4 (5.0–6.1) 5.5 (5.1–6.4) 5.8 (5.2–7.2)
2/h postload glucose (mmolILj1)* 6.3 (5.1–9.3) 5.9 (4.8–7.9) 6.2 (5.1–8.8) 6.8 (5.3–11.6)
Fasting insulin (pmolILj1) 61.3 (42.5–94.3) 54.7 (38.7–83.0) 60.4 (43.9–88.4) 71.6 (44.9–113.2)
HbA1c (mmolImolj1) 38.0 (35.0–44.0) 37.0 (34.5–41.0) 38.0 (35.0–43.0) 40.0 (35.0–48.0)
HbA1c (%) 5.6 (5.6–6.2) 5.6 (5.3–5.9) 5.6 (5.3–6.1) 5.8 (5.4–6.6)
Metabolic syndrome (%) 38.6 27.5 35.7 52.5
Valid days (n) 6.3 T 1.2 6.2 T 1.3 6.4 T 1.1 6.2 T 1.2
Waking time (hIdj1) 15.7 T 0.9 15.6 T 0.9 15.6 T 0.9 16.0 T 0.9
Sedentary time (hIdj1) 9.4 T 1.7 7.7 T 1.0 9.4 T 0.7 11.1 T 1.0
Standing time (hIdj1) 4.3 T 1.3 5.4 T 1.2 4.2 T 0.9 3.3 T 0.9
Stepping time (hIdj1) 2.0 T 0.7 2.5 T 0.7 2.0 T 0.5 1.5 T 0.5
Data are presented as mean T SD or median (25%–75%), unless stated otherwise.
*N = 2048 in total group; n = 706 in tertile 1; N = 698 in tertile 2; N = 644 in tertile 3.
http://www.acsm-msse.org1354 Official Journal of the American College of Sports Medicine
EP
ID
EM
IO
LO
G
Y
Copyright © 2017 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
with 30 min of standing was associated with a 0.41-cm more
favorable waist circumference (Bsedentary-standing =j0.41, 95%
confidence interval [CI] = j0.60 to j0.21), whereas a re-
placement with stepping was associated with a 1.42-cm more
favorable waist circumference (Bsedentary-stepping = j1.42,
95%CI =j1.78 toj1.06). After adjustment for confounders,
associations with a more favorable BMI were seen when
sedentary time was replaced by stepping (Bsedentary-stepping =
j0.48, 95% CI = j0.62 to j0.35), or when standing was
replaced by stepping (Bstanding-stepping = j0.44, 95% CI =
j0.61 to j0.27). Such replacement effects of stepping were
also seen for HDL cholesterol (Bsedentary-stepping = 0.04, 95%
CI = 0.03–0.05; Bstanding-stepping = 0.04, 95% CI = 0.02–0.05),
and 2 h postload glucose levels (Bsedentary-stepping = 0.98, 95%
CI = 0.97–0.99; Bstanding-stepping = 0.98, 95% CI = 0.97–0.99;
back-transformed from log scale). For total-to-HDL cholesterol
ratio, triacylglycerol, and fasting insulin levels, reallocating
sedentary time to standing or to stepping resulted in lower total-
to-HDL ratios (Bsedentary-standing = 0.99, 95% CI = 0.99–1.00;
Bsedentary-stepping = 0.98, 95% CI = 0.97–0.99; back-transformed
from log scale), lower triacylglycerol levels (Bsedentary-standing =
0.99, 95% CI = 0.98–1.00; Bsedentary-stepping = 0.98, 95% CI =
0.96–0.99; back-transformed from log scale), and lower fasting
insulin levels (Bsedentary-standing = 0.99, 95% CI = 0.98–1.00;
Bsedentary-stepping = 0.97, 95% CI = 0.95–0.99; back-transformed
from log-scale).
Figure 1 presents the estimated effects on metabolic syn-
drome and type 2 diabetes of replacing 30 min of one type of
behavior with another. After adjustment for confounders, as-
sociations with the metabolic syndrome were seen when seden-
tary time was replaced by either standing (ORsedentary-standing =
0.93, 95% CI = 0.89–0.97) or stepping (ORsedentary-stepping =
0.72, 95% CI = 0.66–0.78), and when standing was replaced
by stepping (ORstanding-stepping = 0.77, 95% CI = 0.70–0.86).
Similar results were seen for type 2 diabetes; after adjustment
for confounders, associations were seen when sedentary
time was replaced by standing (ORsedentary-standing = 0.94, 95%
CI = 0.90–0.99) or stepping (ORsedentary-stepping = 0.79, 95%
TABLE 2. Estimated effects of replacing 30 min sedentary time or standing with 30 min standing or stepping on cardiometabolic outcomes using isotemporal substitution models.
Standing (30 minIdj1) Stepping (30 minIdj1)
B (95% CI) B (95% CI)
Waist circumference (cm) Sedentary time replaced by j0.405 (j0.60 to -0.21) j1.422 (j1.78 to j1.06)
Standing replaced by — j1.017 (j1.47 to j0.56)
BMI (kgImj2) Sedentary time replaced by j0.038 (j0.11 to 0.03) j0.480 (j0.62 to j0.35)
Standing replaced by — j0.443 (j0.61 to j0.27)
HDL cholesterol (mmolILj1) Sedentary time replaced by 0.005 (0.00 to 0.01) 0.041 (0.03 to 0.05)
Standing replaced by — 0.036 (0.02 to 0.05)
Total-to-HDL cholesterol ratio (mmolILj1)a Sedentary time replaced by 0.993 (0.99 to 1.00) 0.981 (0.97 to 0.99)
Standing replaced by — 0.988 (0.98 to 1.00)
Triacylglycerol (mmolILj1)a Sedentary time replaced by 0.991 (0.98 to 1.00) 0.975 (0.96 to 0.99)
Standing replaced by — 0.984 (0.97 to 1.00)
2 h postload glucose (mmolILj1)a,b Sedentary time replaced by 0.999 (1.00 to 1.00) 0.981 (0.97 to 0.99)
Standing replaced by — 0.982 (0.97 to 0.99)
Fasting insulin (pmolILj1)a Sedentary time replaced by 0.987 (0.98 to 1.00) 0.970 (0.95 to 0.99)
Standing replaced by — 0.983 (0.96 to 1.01)
Linear regression results are presented as unstandardized coefficients (B). Betas represent the estimated effect on cardiometabolic outcomes when replacing 30 min of one behavior with
30 min of another behavior. Boldface indicates statistical significance (P G 0.05). Associations were adjusted for sex, age, level of education, waking time, glucose metabolism status,
smoking status, alcohol consumption, energy intake, mobility limitation, prevalent cardiovascular disease, depression, and antihypertensive and lipid-modifying medication. All asso-
ciations except those with waist circumference and BMI were also adjusted for BMI.
aScores are back-transformed from the natural log scale. In these cases, B should be interpreted as proportional change: B G 0 indicates negative association, B = 1 indicates no
association, and B 9 1 indicates a positive association.
bN = 2048.
FIGURE 1—Estimated effects of replacing 30min of sedentary time or standing with 30min of standing or stepping on the metabolic syndrome and type 2
diabetes, using ISM. Odds ratios represent the odds for metabolic syndrome or type 2 diabetes when replacing 30 min of one behavior with 30 min of
another behavior. Associations were adjusted for sex, age, level of education, waking time, smoking status, alcohol consumption, energy intake, mobility
limitation, prevalent cardiovascular disease, and depression. Type 2 diabetes was also adjusted for BMI.
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CI = 0.72–0.87), and when standing was replaced by stepping
(ORstanding-stepping = 0.84, 95% CI = 0.74–0.95).
Additional Analyses
In additional analyses, interaction terms between stepping
and glucose metabolism status were statistically significant
for waist circumference, BMI, and fasting insulin (all P G
0.10). Therefore, the replacement analyses were repeated
according to glucose metabolism status. Figure 2 presents
the estimated effects on waist circumference and BMI of
replacing 30 min of sedentary time with equal amounts of
standing or stepping, in the NGM, prediabetes, and type 2
diabetes groups. Replacing sedentary time with standing as
well as stepping was associated with a more favorable waist
circumference in all groups, but larger effects were seen in
the prediabetes and type 2 diabetes groups compared with the
NGM group. For example, replacing sedentary time with
stepping was associated with a 1.05-cm more favorable waist
circumference in the NGM group (Bsedentary-stepping = j1.05,
95% CI = j1.47 to j0.63), whereas this was 1.70 cm
(Bsedentary-stepping = j1.70, 95% CI = j2.67 to j0.74) and
1.89 cm (Bsedentary-stepping =j1.89, 95% CI =j2.73 toj1.06)
in the prediabetes and type 2 diabetes groups, respectively. A
similar pattern was seen for BMI: replacing sedentary time with
stepping was associated with a 0.36-kgImj2 more favorable
BMI in the NGM group (Bsedentary-stepping = j0.36, 95% CI =
j0.51 toj0.20), whereas thiswas 0.62 kgImj2 (Bsedentary-stepping =
j0.62, 95% CI = j0.98 to j0.26) in the prediabetes group
and 0.62 kgImj2 (Bsedentary-stepping = j0.62, 95% CI = j0.95
to j0.30) in the type 2 diabetes groups. Although a statisti-
cally significant interaction term was found between stepping
and glucose metabolism status for fasting insulin, the re-
placement effects on fasting insulin in the NGM, prediabetes,
and type 2 diabetes groups were similar (data not shown).
Further, in additional analyses, using 24-h average ambula-
tory blood pressure instead of office blood pressure resulted in
similar findings; no associations were seen with any type of
behavior (data not tabulated). Also, all results remained similar
whenwe excluded participants having less than four valid days.
DISCUSSION
In this study, we used the ISM approach to estimate the
effects of a theoretical reallocation of sedentary behavior (sitting
or lying) to standing or steppingwith cardiometabolic outcomes,
metabolic syndrome, and type 2 diabetes. The results show that,
after adjustment for confounders, reallocating 30 min of seden-
tary time per day to standing or stepping was significantly as-
sociated with 7% to 28% lower odds for metabolic syndrome
and 6% to 21% lower odds for type 2 diabetes. Further, replac-
ing sedentary behavior with nonsedentary behavior was benefi-
cially associated with several metabolic outcomes. The largest
estimated effects were seenwhen sedentary timewas replaced by
stepping: replacing 30 min sedentary time per day by stepping
resulted in a 1.4-cm more favorable waist circumference, a
0.5-kgImj2 more favorable BMI, and improved levels of cho-
lesterol (bothHDL and total-to-HDL ratio), triacylglycerol, and 2/h
postload glucose. Also, the replacement of sedentary behavior
with standing was associated with a more favorable waist cir-
cumference, a lower total-to-HDL cholesterol ratio, a lower
triacylglycerol level, and a lower insulin level. In addition, re-
ducing standing by replacing it with stepping was associated
with more favorable waist circumference and BMI, improved
HDL cholesterol, and 2/h postload glucose levels and lower
odds for metabolic syndrome and type 2 diabetes. Finally, when
estimating the effects of replacing sedentary time with standing
or stepping in groups according to glucose metabolism status,
larger replacement effects were seen in participants with predi-
abetes and type 2 diabetes compared with participants with
NGM for both waist circumference and BMI. However, this
was likely due to the larger measures of waist circumference and
BMI in the prediabetes and type 2 diabetes groups rather than
glucose metabolism per se. Taken together, the results suggest
that reallocating sedentary behavior, even in relatively small
amounts of 30 minIdj1, may have favorable effects on
FIGURE 2—Estimated effects of replacing 30 min of sedentary time with 30 min of standing or stepping on waist circumference and BMI, according
to glucose metabolism status, using ISM. Regression coefficients represent the estimated effect on waist circumference and BMI when replacing 30 min
of one behavior with 30 min of another behavior. Associations were adjusted for sex, age, level of education, waking time, smoking status, alcohol
consumption, energy intake, mobility limitation, prevalent cardiovascular disease, depression, and antihypertensive and lipid-modifying medication.
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metabolic outcomes, metabolic syndrome, and type 2 diabetes.
Interestingly, these favorable results were not only seen when
sedentary time was replaced by stepping (e.g., physical activity),
but also when it was replaced by standing. Also, as stronger
associations for waist circumference and BMI were seen in
participants with prediabetes and type 2 diabetes, reallocation of
only 30 min of sedentary time per day to standing or stepping
may be clinically relevant. Thus, our results provide new insight
into the potential effects of reallocating sedentary time, which
may be used for health guidelines and may also give direction
to experimental or intervention studies on the amounts of
reallocation time that should be examined. For these reasons,
our findings are relevant for the general population, for those
who cannot participate in high-intensity activities, and for those
who cannot meet the physical activity guidelines.
Our results are in line with findings of previous studies
using the ISM approach. Most of these studies reported
associations of reallocating sedentary time to LPA or MVPA
with reductions in waist circumference (6,11,12,17,18) and
BMI (12,14,17,18). Less consistent results were seen for
other metabolic outcomes including levels of cholesterol,
triacylglycerol, and glucose. In a few studies including ours
(11,18), statistically significant associations were seen with
HDL cholesterol when replacing sedentary time with more
active types of behavior, whereas other studies showed no
associations (12) or only associations with MVPA (6,14).
Similar inconsistencies were seen for triacylglycerol (6,11,14,18)
and glucose levels (6,11,18,29). These inconsistencies could
be due to the study population, which varied in age (36 to
80 yr) and in metabolic profile (healthy participants, partici-
pants at increased risk for type 2 diabetes, and participants with
type 2 diabetes). In addition, the replacement time varied be-
tween studies, as some studies used blocks of 10 min (11,14),
whereas we and others used 30-min blocks (6,17,29), and even
2-h blocks were used (18). Further, most studies used a waist-
or hip-worn accelerometer, which cannot distinguish between
postures. Consequently, estimations of the amount of seden-
tary time in these studies were less accurate than the estimates in
our study, as we used a posture-based accelerometer (13,20,21).
In only one other study, a posture-based accelerometer was
used, and the reported results were similar to ours, although in
that study an allocation time of 2 h was used (18).
Possible pathophysiological mechanisms that may explain
our findings have not yet been studied extensively. However,
animal studies have described plausible mechanisms that may
underlie the detrimental health effects of large amounts of
sedentary time, including reductions in lipoprotein lipase and
lipid phosphate phosphatase 1, because of muscle inactivity
(15,16). Participation in nonsedentary behavior may be suf-
ficient to counterbalance these processes. It has been shown
that reducing inactivity by low-intensity activities, such as
walking and standing, was effective in improving insulin level
and plasma lipids, which supports our hypothesis (9). In ad-
dition, previous experimental and epidemiological studies have
demonstrated that breaking up sedentary time with nonsedentary
time had beneficial effects on metabolic outcomes, which
supports also this hypothesis (3). Nevertheless, physiological
studies are needed to further examine this.
The use of posture-based accelerometer was a key strength
of this study, as well as the large study population consisting
of adults with NGM, prediabetes, and type 2 diabetes. Another
strength of this study was adjustment for a series of relevant
confounders, including total energy intake. However, this
could have resulted in overadjustment bias as an increase in
standing or stepping could result in a higher energy intake.
A few limitations should also be mentioned. Because of the
cross-sectional nature of the study, causal relationships could
not be determined and reverse causality could not be excluded.
Moreover, the replacement effects resulting from the ISM
approach were estimated rather than based on actual behav-
ioral reallocation. Although this method can provide valuable
insights into the potential effects on health, experimental and
intervention studies are warranted to examine the actual be-
havioral reallocation effects on both short and long term.
Further, as our accelerometry data were posture based, we
used total stepping time as a measure for physical activity, but
different intensity levels were not determined. In addition,
stepping time was not classified into higher and lower inten-
sity stepping because the associations of lower intensity
stepping with the outcome measures were nonlinear. There-
fore, future studies ideally should combine posture-based data
for accurate assessment of sedentary behavior with accelera-
tion data for determining physical activity intensity levels. In
addition, because of missing data, we had to exclude 1200
participants. However, the excluded participants did not differ
from our study sample with regard to demographic factors,
accelerometry variables, and outcomes measures (data not
shown). Finally, our study population consisted of a relatively
healthy population, including individuals with well-controlled
type 2 diabetes; therefore, the results might not be represen-
tative for the general population of adults 40–75 yr of age.
To conclude, our study demonstrated that a theoretical
replacement of sedentary time with standing or stepping was
associated with a decreased likelihood for metabolic syn-
drome and type 2 diabetes, more favorable waist circum-
ference and BMI, and improved levels of HDL cholesterol,
triacylglycerol, glucose, and insulin. In addition, replacing
standing with stepping was associated with an improved
waist circumference, BMI, HDL cholesterol and glucose
level, metabolic syndrome, and type 2 diabetes. Further, the
theoretical replacement effects for both waist circumference
and BMI were larger in participants with prediabetes and type
2 diabetes. As reallocating of even small amounts of sedentary
behavior to any type of nonsedentary behavior seems to be
beneficial for health, consideration should be given to devel-
oping health guidelines that include recommendations for the
daily reallocation of sedentary time, although longitudinal and
intervention studies on actual behavioral reallocation effects
are needed to confirm our results.
The researchers are indebted to the participants for their willing-
ness to participate in the study.
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